Writing 5 min read

Your Patients Are Already in Therapy With a Chatbot

Nearly 1 in 5 young people already use AI chatbots for mental health, mostly in secret. Before you have an opinion about it, look at why they do it.

Your Patients Are Already in Therapy With a Chatbot

Photo by Shvets Production on Pexels

The short answer

Nearly 1 in 5 US young people already use AI chatbots for mental health advice, most without telling anyone, according to RAND. Most use general assistants not designed for care, though at least one randomized trial shows a purpose-built therapy chatbot can reduce symptoms. The honest read: patients turned to chatbots because real care was hard to get. Health systems should assume it is happening, distinguish tested clinical tools from general bots, build crisis handoffs, and treat it as the access-gap signal it is.

I want to start with a number that quietly reframes the whole debate about AI and mental health, because most of that debate is aimed at the wrong question. While we argue about whether AI therapy is a good idea, RAND went and measured what is actually happening, and found that nearly one in five US young people already use AI chatbots for mental health advice, most of them without telling a single adult. This is not a future policy question. Your patients, and quite possibly your kids, are already doing it, quietly, tonight. The debate is over. The only choice left is how we respond.

The number that should reframe your access strategy

Sit with the full picture for a second, because each number pulls in a different direction and together they tell the real story.

19%
of 12-21 year olds use AI chatbots for mental health
63%
have told no one they do
92%
found the advice helpful
40%
jump in use in a single year

Ninety-two percent found it helpful, and sixty-three percent told no one. Read those two together and you get both the appeal and the danger in one breath. Something is meeting a need so real that millions of kids reach for it, and doing so in the dark, where no parent, teacher, or clinician can see whether the advice was good, bad, or dangerous. That is not a technology story. That is an access story, and it is a loud one.

Two very different things are both called AI therapy

Before anyone panics or celebrates, we have to separate two things that get lumped together and could not be more different. One is the general chatbot your patient already talks to. The other is a purpose-built clinical tool. Confusing them is the single biggest mistake in this whole conversation.

The chatbot your patient already usesA purpose-built, tested therapy tool
What it isA general assistant or a companion appA clinical tool designed and trialed for mental health
EvidenceAlmost none for treatmentAt least one randomized trial showing symptom reduction
Safety designNot built for a crisisBuilt with escalation and guardrails
AccountabilityEffectively no oneThe developer and the clinician
The riskConfident, unmonitored adviceStill needs oversight, but far more defensible

Here is the gut-punch in that table: almost everyone in that 19 percent is in the left column, and almost all of the reassuring evidence lives in the right one. We are pointing at a well-designed clinical trial to feel better about a behavior that has nothing to do with it.

The evidence, honestly

I do not want to be the cynic who only sees the downside, because there is real and encouraging news. A randomized trial of a purpose-built generative AI therapy chatbot, published in NEJM AI, found meaningful reductions in depression and anxiety symptoms. That matters, and it points at a future where a well-built tool genuinely extends care to people who have none. But hold the caveat right next to the hope: that trial tested a careful, supervised clinical tool. It does not vouch for the general-purpose chatbot a teenager is confiding in at midnight. One rigorous study of the good version is not a permission slip for millions of conversations happening on the untested one.

What a responsible health system does now

Wringing our hands is not a strategy, and banning it is a fantasy. The behavior is already here, so the job is to make it safer. That looks like this.

01

Assume it is happening

Ask about AI use without judgment. Most patients will not volunteer it.

02

Screen for the real thing

A chatbot chat is not a diagnosis. Use it as a prompt to assess properly.

03

Point to evidence-based tools

Guide patients to tested options, not whatever the app store surfaced.

04

Build a crisis path

When a conversation turns serious, the handoff to a human must be fast and certain.

05

Close the access gap

They reached for a bot because you were not reachable. Fix that.

Your patients did not choose a chatbot over a therapist. They chose a chatbot over nothing, because nothing was often what they could actually get.

Naveen Kumar

If you take one thing from this, let it be step five. The 19 percent is not really a story about AI being seductive. It is a story about care being unreachable, and a chatbot being the only thing awake at 2am that would listen without a wait list, a copay, or a raised eyebrow. Fix that gap and the chatbot becomes a supplement instead of a substitute. Ignore it and we are just letting the most vulnerable people quietly beta-test unregulated software on their own minds.

A serious closing note, because this topic earns it. Mental health is tender ground, and for anyone truly struggling, an AI chatbot is not a substitute for a trained human, least of all in a crisis. The most important thing any team deploying these tools can build is the fast, reliable moment when the bot steps back and a real person steps in. Get that one handoff right and much can be forgiven. Get it wrong and nothing else you built will matter.

Key takeaways
  • Nearly 1 in 5 US 12-to-21-year-olds use AI chatbots for mental health advice, up 40% in a year, and most have told no one.
  • Most use general assistants with almost no treatment evidence, not purpose-built clinical tools.
  • At least one randomized trial shows a purpose-built therapy chatbot can meaningfully reduce depression and anxiety symptoms.
  • This is an access story: patients chose a chatbot over nothing, because nothing was often the alternative.
  • Respond by assuming it is happening, guiding to evidence-based tools, and building a fast crisis handoff.

Frequently asked

How many young people use AI for mental health?

RAND found about 19% of US 12-to-21-year-olds use AI chatbots for mental health advice, up from about 13% a year earlier, and roughly 63% have not told a parent, clinician, or other adult.

Are these real therapy tools?

Mostly no. Most use general assistants like ChatGPT or companion apps, which are not designed or tested for mental health treatment. That is different from a purpose-built clinical tool.

Is there any evidence AI therapy works?

There is early, real evidence. At least one randomized trial of a purpose-built generative AI therapy chatbot showed meaningful reductions in depression and anxiety symptoms. One trial is a start, not settled science, and it does not validate the general chatbots most people actually use.

Why are patients turning to chatbots?

Access. Mental health care is scarce, expensive, and stigmatized, and a chatbot is available at 2am for free and without judgment. The behavior is a signal about the gap in the system more than an endorsement of the technology.

What should health systems do?

Assume patients are already using it and ask without judgment, distinguish tested tools from general bots, point people to evidence-based options, and above all build a fast, reliable handoff to a human when a conversation signals crisis.

Sources

Naveen Kumar

Naveen Kumar

Healthcare engineering and product executive in Pittsburgh. 15+ years building AI-first patient access, a decade at Treatspace.

Read next